BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 9794475)

  • 1. Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphtheria toxin A) mice.
    Tritos NA; Elmquist JK; Mastaitis JW; Flier JS; Maratos-Flier E
    Endocrinology; 1998 Nov; 139(11):4634-41. PubMed ID: 9794475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations.
    Mantzoros CS; Frederich RC; Qu D; Lowell BB; Maratos-Flier E; Flier JS
    Diabetes; 1998 Feb; 47(2):230-8. PubMed ID: 9519718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus.
    Tritos NA; Mastaitis JW; Kokkotou E; Maratos-Flier E
    Brain Res; 2001 Mar; 895(1-2):160-6. PubMed ID: 11259773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids are required for meal-induced changes in the expression of hypothalamic neuropeptides.
    Uchoa ET; Silva LE; de Castro M; Antunes-Rodrigues J; Elias LL
    Neuropeptides; 2012 Jun; 46(3):119-24. PubMed ID: 22425130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.
    Bergen HT; Mizuno TM; Taylor J; Mobbs CV
    Endocrinology; 1998 Nov; 139(11):4483-8. PubMed ID: 9794456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
    Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
    Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
    Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
    Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting.
    Hahm S; Fekete C; Mizuno TM; Windsor J; Yan H; Boozer CN; Lee C; Elmquist JK; Lechan RM; Mobbs CV; Salton SR
    J Neurosci; 2002 Aug; 22(16):6929-38. PubMed ID: 12177191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.
    Korner J; Savontaus E; Chua SC; Leibel RL; Wardlaw SL
    J Neuroendocrinol; 2001 Nov; 13(11):959-66. PubMed ID: 11737554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent hypothalamic expression of neuropeptides in wild-type and melanocortin-4 receptor-deficient mice.
    Arens J; Moar KM; Eiden S; Weide K; Schmidt I; Mercer JG; Simon E; Korf HW
    Physiol Genomics; 2003 Dec; 16(1):38-46. PubMed ID: 14559977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.
    Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV
    Diabetes; 2000 Nov; 49(11):1917-23. PubMed ID: 11078460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neuropeptide Y in diet-, chemical- and genetic-induced obesity of mice.
    Hollopeter G; Erickson JC; Palmiter RD
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):506-12. PubMed ID: 9665670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus.
    Dhillon H; Kalra SP; Kalra PS
    Mol Ther; 2001 Aug; 4(2):139-45. PubMed ID: 11482985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake.
    Denis RG; Bing C; Brocklehurst S; Harrold JA; Vernon RG; Williams G
    J Endocrinol; 2004 Oct; 183(1):173-81. PubMed ID: 15525585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression.
    Wang H; Storlien LH; Huang XF
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1352-9. PubMed ID: 12006366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice.
    Sindelar DK; Mystkowski P; Marsh DJ; Palmiter RD; Schwartz MW
    Diabetes; 2002 Mar; 51(3):778-83. PubMed ID: 11872679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC.
    Hotta K; Hosaka M; Tanabe A; Takeuchi T
    J Endocrinol; 2009 Jul; 202(1):111-21. PubMed ID: 19357184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake.
    Proulx K; Richard D; Walker CD
    Endocrinology; 2002 Dec; 143(12):4683-92. PubMed ID: 12446596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
    Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS
    Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy.
    Bagnasco M; Dube MG; Kalra PS; Kalra SP
    Endocrinology; 2002 Nov; 143(11):4409-21. PubMed ID: 12399438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.